Last reviewed · How we verify

NCT04263662

Implementation of an Analgesia-sedation Algorithm in the Pediatric ICU to Reduce Benzodiazepine Use

Completed Last updated 6 January 2021
What this trial tests

trial testing Analgesia-Sedation algorithm in Mechanical Ventilation in 680 participants. Completed in 1 March 2020.

Timeline
1 August 2017
Primary endpoint
1 March 2020
1 March 2020

Quick facts

Lead sponsorBoston Children's Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment680
Start date1 August 2017
Primary completion1 March 2020
Estimated completion1 March 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Boston Children's Hospital

Who can join

Under 25, any sex, with Mechanical Ventilation or Sedation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to develop and implement an evidence-based analgesia-sedation algorithm in the pediatric intensive care unit (PICU) using quality improvement and implementation science methodology. The analgesia-sedation protocol will be implemented for patients admitted to the pediatric ICU who require mechanical ventilation for greater than 24 hours. Specifically, we will examine the impact of this implementation on total benzodiazepine usage, ICU length of stay, and ventilator free days, using a pre- and post- algorithm implementation comparative design.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mechanical Ventilation

Currently open trials in the same condition.

Other Boston Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04263662.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing